Genome Map Raises Hope For Vaccine Against Facial Tumour

.

Genome Map Raises Hope For Vaccine Against Facial Tumour

It has been found in a recent report that Tasmania fears the outbreak of devil facial tumour disease (DFTD) in the state, which has already targeted many. As per the report, the disease victimizes only devil populations and is relatively firm.

According to the report findings, a team at the Australian National University had conducted a research, which led them to find out that the fragments of the chromosomes had been jumbled up between the normal Tasmanian devil genome and devil facial tumours.

The team of researchers created a genome map of the facial tumour that led them to conclude that the tumour had a massive number of unusual features. As per their belief, the facial tumour, which is the major cause of deaths in the state, might be killed as the genome map had given them a hope of understanding its origin.

The study has revealed that the tumour had initially emerged in the year 1996 and has been constant and unchanged since then. The team told the reporters that the tumour has been continuously and steadily developing from when it originated years ago. After studying three strains of the tumour, the researchers were able to determine different rearrangements.

However, it has been told by the team that the rearrangements inside different strains were similar that concerned them of the stability of the facial tumour. But, its stability further gave the team a hope of developing a treatment for the same. “The Devil is going to be a good model for looking at some human cancers because it is so stable – with everything happening slower we have a better chance of finding those things out”, said the team. It concluded that the map completed may be helpful in discovering a vaccine against the disease.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves